Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

21.20 +8.42 (+65.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 78,373,825
Open 21.13
Bid (Size) 21.15 (4,100)
Ask (Size) 21.23 (1,600)
Prev. Close 12.78
Today's Range 21.08 - 21.23
52wk Range 5.635 - 21.23
Shares Outstanding 73,572,633
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions ↗
Energy names climb while most U.S. stocks retreat on stagflation fears and war-driven oil gains, today, March 6, 2026. 
Via The Motley Fool
Topics Economy Stocks

Performance

YTD
+139.5%
+139.5%
1 Month
+97.4%
+97.4%
3 Month
+167.7%
+167.7%
6 Month
+180.8%
+180.8%
1 Year
+133.0%
+133.0%

More News

Read More
Here are the top movers in Friday's session. ↗
Via Chartmill
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q4 Revenue Beat but Wider Loss, Shares Dip ↗
Via Chartmill
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
The market is filled with gapping stocks in Friday's session. ↗
Via Chartmill
News headline image
Why Did DAWN Skyrocket Over 65% Pre-Market Today? ↗
Via Stocktwits
News headline image
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise ↗
Via Stocktwits
Topics Economy
News headline image
Day One Bio (DAWN) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Gapping stocks in Monday's session ↗
Via Chartmill
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
News headline image
Day One Completes Acquisition of Mersana Therapeutics
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’ ↗
Via Stocktwits
News headline image
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout ↗
Via Benzinga

Frequently Asked Questions

Is Day One Biopharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Day One Biopharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Day One Biopharmaceuticals, Inc. - Common Stock trade on?
Day One Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock?
The ticker symbol for Day One Biopharmaceuticals, Inc. - Common Stock is DAWN on the Nasdaq Stock Market
What is the current price of Day One Biopharmaceuticals, Inc. - Common Stock?
The current price of Day One Biopharmaceuticals, Inc. - Common Stock is 21.20
When was Day One Biopharmaceuticals, Inc. - Common Stock last traded?
The last trade of Day One Biopharmaceuticals, Inc. - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock?
The market capitalization of Day One Biopharmaceuticals, Inc. - Common Stock is 1.56B
How many shares of Day One Biopharmaceuticals, Inc. - Common Stock are outstanding?
Day One Biopharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.